Foreign drug companies created 370 MW of sales per capita.

Yakup Press unveiled in its survey that 22 foreign multinational drug corporations in Korea have achieved 370 million won of sales per capita in 2003 (an average employee of 269.32/company), which was 1.6 times more than 24 domestic listed companies of 223 million won.

Organon Korea ran the top at 729MW, then, Sanofi at 577MW and Pfizer Korea at 566MW.

Number of employees showed the l...